Antidepressants and brain neurochemistry

Mayo Clin Proc. 1990 Sep;65(9):1227-36. doi: 10.1016/s0025-6196(12)62747-5.

Abstract

Most antidepressant drugs prescribed today have been available for decades. Nonetheless, their mechanism of action in treating depression has remained elusive. On the basis of neurochemical studies in laboratory animals, hypotheses explaining their therapeutic effects have been formulated. The most attractive of these theories involves antidepressant-induced changes in the sensitivity of certain catecholamine and serotonergic receptors in the brain. Support for this hypothesis from clinical studies has been difficult to obtain. Pharmacologic studies of antidepressant drugs, however, indicate the involvement of blockade of neuronal uptake systems for norepinephrine and serotonin and blockade of many receptors for neurotransmitters. These properties of antidepressants can explain some of their adverse effects and certain interactions with other drugs.

Publication types

  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Animals
  • Antidepressive Agents / adverse effects
  • Antidepressive Agents / pharmacology*
  • Antidepressive Agents / therapeutic use
  • Brain Chemistry / drug effects*
  • Drug Interactions
  • Humans
  • Norepinephrine / blood
  • Rats
  • Receptors, Muscarinic / drug effects
  • Receptors, Neurotransmitter / drug effects*
  • Receptors, Serotonin / drug effects*
  • Serotonin / analysis
  • Synaptic Transmission / drug effects*
  • Time Factors

Substances

  • Antidepressive Agents
  • Receptors, Muscarinic
  • Receptors, Neurotransmitter
  • Receptors, Serotonin
  • Serotonin
  • Norepinephrine